Barendrecht Maurits M, Oelke Matthias, Laguna Maria P, Michel Martin C
Department of Urology, Academic Medical Center, Amsterdam, The Netherlands.
BJU Int. 2007 Apr;99(4):749-52. doi: 10.1111/j.1464-410X.2006.06742.x. Epub 2007 Mar 16.
An underactive urinary bladder (UUB), often occurring after surgery, can lead to urinary retention even in otherwise healthy people. We systematically reviewed published reports to determine whether the use of parasympathomimetic agents is warranted in patients with a UUB. Agents allegedly useful in treating UUB were identified from urology and pharmacology textbooks. A systematic search for randomized clinical trials in patients with UUB using these agents revealed 10 such studies. Controls typically received placebo or no treatment. While three studies reported statistically significant improvements relative to the control group, six did not and one even reported a significant worsening of symptoms. There was no evidence for differences between individual drugs, specific uses of such drugs, or in outcome measures. We conclude that the available studies do not support the use of parasympathomimetics for treating UUB, specifically when frequent and/or serious possible side-effects are taken into account.
膀胱功能减退(UUB)常发生于手术后,即使是原本健康的人也可能导致尿潴留。我们系统回顾了已发表的报告,以确定拟副交感神经药是否适用于膀胱功能减退患者。从泌尿学和药理学教科书中找出据称对治疗膀胱功能减退有用的药物。对使用这些药物的膀胱功能减退患者进行随机临床试验的系统检索发现了10项此类研究。对照组通常接受安慰剂或不接受治疗。虽然三项研究报告相对于对照组有统计学上的显著改善,但六项研究没有,甚至有一项研究报告症状显著恶化。没有证据表明不同药物、此类药物的特定用途或结果指标之间存在差异。我们得出结论,现有研究不支持使用拟副交感神经药治疗膀胱功能减退,特别是考虑到频繁和/或严重的可能副作用时。